EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.76 BILLION IN 2024 -- ...

The China stock market has moved higher in back-to-back sessions, collecting almost 25 points or 0.8 percent along the way. The ...

The Taiwan stock market on Wednesday snapped the three-day winning streak in which it had spiked more than 800 points or 3.4 percent.

The Hong Kong stock market has finished lower in three straight sessions, retreating more than 480 points or 2.6 percent along the ...

The Singapore stock market has moved higher in five straight sessions, gathering more than 100 points or 1.5 percent along the way.

The Australian market is trading notably lower on Thursday, snapping a five-session winning session, following the mixed cues from ...

Many Federal Reserve officials believe a careful approach to interest rate decisions will be necessary over the coming quarters, ...

Time and date: 2.00 p.m. Wednesday, 29 January 2025 Place: The company’s address: Hjulmagervej 55, 9000 Aalborg, Denmark ...

Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...